Investors looking for promising opportunities may want to turn their attention to the latest additions to the Zacks Rank #1 (Strong Buy) List. Here are five stocks added today:
Skyward Specialty Insurance Group, Inc. (SKWD) has made impressive strides with a 6.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The insurance holding company is focused on underwriting commercial property and casualty insurance coverages primarily in the United States.
Skyward Specialty Insurance Group, Inc. Performance and Forecast
View performance and forecast | Skyward Specialty Insurance Group, Inc. Quote
Koninklijke Philips (PHG), a health technology company, has witnessed a 4.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The company caters to various segments, including diagnosis & treatment Businesses, connected care businesses, and personal health businesses.
Koninklijke Philips N.V. Performance and Forecast
View performance and forecast | Koninklijke Philips N.V. Quote
The Bank of New York Mellon (BK), a financial services company operating in 35 countries, has enjoyed a 2.2% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The company provides a wide array of products and services to individuals and institutions.
The Bank of New York Mellon Corporation Performance and Forecast
View performance and forecast | The Bank of New York Mellon Corporation Quote
PagSeguro Digital (PAGS), offering financial technology solutions and services for micro-merchants and small and medium-sized businesses primarily in Brazil and internationally, has seen a 2.0% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
PagSeguro Digital Ltd. Performance and Forecast
View performance and forecast | PagSeguro Digital Ltd. Quote
Genmab (GMAB), a biotechnology company specializing in the development of antibody therapeutics for cancer treatment, has experienced a 1.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Genmab A/S Sponsored ADR Performance and Forecast
View performance and forecast | Genmab A/S Sponsored ADR Quote
For the complete list of today’s Zacks #1 Rank (Strong Buy) stocks, click here.
An Opportunity Not to Be Missed
Several years ago, Zacks shocked its members by offering 30-day access to all its picks for just $1 – and there was no catch. This offer aimed to familiarize investors with portfolio services likeSurprise Trader, Stocks Under $10,and more, which have already closed 162 positions with double- and triple-digit gains in 2023 alone.
Don’t miss out on this opportunity. See Stocks Now >>
Read the original article on Zacks.com here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
